Back
Cyclo Therapeutics Quote, Financials, Valuation and Earnings
NOW is the time to get in on this trillion-dollar megatrend
Get it here.
Sell
41
CYTH
Cyclo Therapeutics
Last Price:
1.44
Seasonality Move:
4.15%
7 Day Trial
ALL ACCESS PASS
$
7
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the cornerCyclo Therapeutics Price Quote
$1.44
-0.03 (-2.04%)
(Updated: April 30, 2024 at 1:50 PM ET)
Cyclo Therapeutics Key Stats
Sell
41
Cyclo Therapeutics (CYTH)
is a Sell
Day range:
$1.28 - $1.47
52-week range:
$0.89 - $2.57
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
21.64
P/B ratio:
8.87%
Volume:
56.4K
Avg. volume:
90.3K
1-year change:
49.95%
Market cap:
$42.2M
Revenue:
$1.1M
EPS:
$-1.31
How Much Does Cyclo Therapeutics Make?
-
How Much Are Cyclo Therapeutics's Sales Annually?
CYTH Revenues are $1.1M -
How Much Profit Does Cyclo Therapeutics's Make A Year?
CYTH net income is -$20.1M
Is Cyclo Therapeutics Growing As A Company?
-
What Is Cyclo Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.67% -
What Is Cyclo Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Cyclo Therapeutics Stock Price Performance
-
Did Cyclo Therapeutics Stock Go Up Last Month?
Cyclo Therapeutics share price went up by 5.76% last month -
Did CYTH's Share Price Rise Over The Last Year?
CYTH share price rose by 49.95% over the past 1 year
What Is Cyclo Therapeutics 52-Week High & Low?
-
What Is Cyclo Therapeutics’s 52-Week High Share Price?
Cyclo Therapeutics has traded as high as $2.57 over the past 52 weeks -
What Is Cyclo Therapeutics’s 52-Week Low Share Price?
Cyclo Therapeutics has traded as low as $0.89 over the past 52 weeks
Cyclo Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Cyclo Therapeutics?
-
How Much Debt Does Cyclo Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Cyclo Therapeutics Have?
Cash and short term investments quarterly total is $9.2M -
What Is Cyclo Therapeutics’s Book Value Per Share?
Book value per share is 0.17
Is Cyclo Therapeutics Cash Flow Positive?
-
What Is CYTH Cash Flow From Operations?
Cash flow from operations (TTM) is -$16.2M -
What Is Cyclo Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $23.9M -
What Is Cyclo Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$2.4K
Cyclo Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
CYTH return on invested capital is -3987.27% -
What Is Cyclo Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -315.37% -
What Is CYTH Return On Equity?
ROE is a measure of profitability and is -3987.27%
Cyclo Therapeutics Earnings Date & Stock Price
-
What Is Cyclo Therapeutics's Stock Price Today?
A single share of CYTH can be purchased today for 1.47 -
What Is Cyclo Therapeutics’s Stock Symbol?
Cyclo Therapeutics trades on the nasdaq under the ticker symbol: CYTH -
When Is Cyclo Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Cyclo Therapeutics is scheduled on May 10, 2024 -
When Is CYTH's next ex-dividend date?
Cyclo Therapeutics's next ex-dividend date is April 30, 2024 -
How To Buy Cyclo Therapeutics Stock?
You can buy Cyclo Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Cyclo Therapeutics Competitors
-
Who Are Cyclo Therapeutics's Competitors?
Below is a list of companies who compete with Cyclo Therapeutics or are related in some way:
Cyclo Therapeutics Dividend Yield
Data Unavailable
Cyclo Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 66.7% | 84.26% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 3.30 |
| Upside from Last Price: | 124.49% |